Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | PRKCB |
| Upstream (Parents) |
|---|
| (<<) ARHGAP25 → PRKCB |
| (<<) CORO1A → PRKCB |
| (<<) PIK3R5 → PRKCB |
| (<<) PTGER4 → PRKCB |
| (<<) RASSF5 → PRKCB |
| (<<) STAT4 → PRKCB |
| Downstream (Children) |
|---|
| PRKCB → ADRBK2 (>>) |
| PRKCB → ARSD (>>) |
| PRKCB → ASB2 (>>) |
| PRKCB → BBS1 (>>) |
| PRKCB → BCL2 (>>) |
| PRKCB → CASP1 (>>) |
| PRKCB → CBFA2T3 (>>) |
| PRKCB → CD274 (>>) |
| PRKCB → CD79A (>>) |
| PRKCB → CLEC2B (>>) |
| PRKCB → ETS1 (>>) |
| PRKCB → GRK5 (>>) |
| PRKCB → HLA-F (>>) |
| PRKCB → HSD11B1 (>>) |
| PRKCB → ICAM2 (>>) |
| PRKCB → INPP5D (>>) |
| PRKCB → IRF1 (>>) |
| PRKCB → JAK3 (>>) |
| PRKCB → LTB (>>) |
| PRKCB → MAL (>>) |
| PRKCB → NR3C1 (>>) |
| PRKCB → PAG1 (>>) |
| PRKCB → PCSK7 (>>) |
| PRKCB → PIK3CD (>>) |
| PRKCB → PIK3CG (>>) |
| PRKCB → PIP4K2A (>>) |
| PRKCB → PLOD2 (>>) |
| PRKCB → PPP3CC (>>) |
| PRKCB → PRKCH (>>) |
| PRKCB → PRKCQ (>>) |
| PRKCB → PSTPIP1 (>>) |
| PRKCB → PTK7 (>>) |
| PRKCB → RAP1A (>>) |
| PRKCB → RBL2 (>>) |
| PRKCB → SOCS1 (>>) |
| PRKCB → STK17A (>>) |
| PRKCB → TRAF1 (>>) |
| PRKCB → VAV1 (>>) |
| PRKCB → ZBED2 (>>) |
